Last reviewed · How we verify
NCT05762445: PACT-CP
PAtient-CenTric Chronic Pancreatitis Registry (PACT-CP)
trial in Chronic Pancreatitis in 400 participants. Completed in 31 August 2025.
31 August 2025
Quick facts
| Lead sponsor | CorEvitas |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 2 June 2021 |
| Primary completion | 31 August 2025 |
| Estimated completion | 31 August 2025 |
| Sites | 1 location across United States |
Conditions studied
- Chronic Pancreatitis — all drugs for Chronic Pancreatitis →
Sponsor
CorEvitas — full company profile →
Who can join
18 and older, any sex, with Chronic Pancreatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this study is to generate real-world evidence reflecting the experience of individuals with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP). Efforts will be directed toward understanding the unmet need and therapeutic burden to identify the most critical factors that influence treatment choices/prescribing patterns, quality of life, and healthcare utilization outcomes in standard of care for individuals with EPI due to CP.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Protocol and Study Population of a Prospective Study of Patients With Chronic Pancreatitis and Exocrine Pancreatic Insufficiency: Preliminary Findings From the PACT-CP Registry Show Reduced Health-related Quality of Life.
Barkin JA, Al-Kaade S, Pannala R, Hernandez-Barco Y, et al · · 2025 · PMID 39977002 · DOI 10.1097/mpa.0000000000002460
Verify or expand the search:
- PubMed search for NCT05762445
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Pancreatitis
Currently open trials in the same condition.
- NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
- NCT06655051 — Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancr · NA · recruiting
- NCT06937294 — Metformin in Post Chronic Pancreatitis Diabetes Mellitus · Phase 4 · recruiting
- NCT07109180 — Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOT · NA · recruiting
- NCT06925204 — Natural Course and Therapeutic Effect of Chronic Pancreatitis · recruiting
Other CorEvitas trials
Trials by the same sponsor.
- NCT07420075 — Alzheimer's Registry · enrolling by invitation
- NCT07217509 — PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry · enrolling by invitation
- NCT06804057 — CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry · recruiting
- NCT06521944 — RSV Vaccine Pregnancy Registry · recruiting
- NCT06562270 — CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05762445 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CorEvitas
- Last refreshed: 22 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05762445.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing